NOROQUIN INJECTION

Indications

• African trypanosomiasis (sleeping sickness)
• Bovine trypanosomiasis
• Equine trypanosomiasis

Dosage

Children: Refer to the BNF for Children for specific pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing information. Doses may vary based on the condition being treated and the weight of the animal.

Mechanism of action

Quinapyramine exerts its pharmacological effects by inhibiting the activity of nucleic acid synthesis in trypanosomes, leading to cell death. Its action is thought to involve interference with mitochondrial function and the disruption of metabolic processes vital for the parasite's survival.

Pharmacodynamics

Quinapyramine demonstrates a selective toxicity towards trypanosomes, affecting their biochemical pathways while sparing host cells. The drug accumulates within the parasites, which enhances its effectiveness, especially in the presence of hypoxic conditions that further promote its uptake. The efficacy of quinapyramine is influenced by factors such as the stage of the disease and the specific trypanosome species involved.

Pharmacokinetics

Quinapyramine is well-absorbed after parenteral administration, with peak plasma concentrations occurring within hours. It has a moderate volume of distribution and is metabolized primarily in the liver. The elimination half-life varies based on the species treated and the route of administration, but it generally undergoes renal excretion. Careful monitoring of plasma levels may be necessary to avoid toxicity.

Pregnancy

There is limited information on the safety of quinapyramine in pregnancy. Caution is advised.

Breast-feeding

It is not known whether quinapyramine is excreted in human milk. Caution is recommended.

Storage

Store at room temperature, away from light and moisture.

Formulations

• {'formulation': 'Quinapyramine', 'type': 'Injection', 'strength': 'available in various strengths'}

Indications

• Allergic rhinitis
• Urticaria
• Allergic conjunctivitis
• Other allergic conditions

Dosage

Children: Refer to established guidelines for appropriate dosing in children, as specific doses may vary based on age and weight.

Adults: Refer to established guidelines for appropriate dosing in adults, as specific doses may vary based on indication and patient response.

Mechanism of action

Quinapytamine works by selectively antagonizing peripheral H1 histamine receptors. By blocking these receptors, it prevents the action of histamine, a substance in the body that is responsible for allergic symptoms such as itching, sneezing, and runny nose. This action leads to a reduction in vascular permeability and smooth muscle contraction, which are hallmarks of allergic reactions.

Pharmacodynamics

The pharmacodynamic profile of quinapytamine demonstrates its ability to reduce the effects of histamine, leading to decreased symptoms of allergies. Its selective action on H1 receptors minimizes side effects associated with central nervous system (CNS) penetration, which is common in first-generation antihistamines. The onset of action typically occurs within hours of administration, with effects lasting for a significant duration, allowing for once-daily dosing in many cases.

Pharmacokinetics

Quinapytamine is absorbed efficiently following oral administration, with peak plasma concentrations usually occurring within a few hours. It undergoes hepatic metabolism and is excreted primarily via the urine. The half-life of quinapytamine allows for once-daily dosing, contributing to its convenience in chronic allergy management. Factors such as age, liver function, and concomitant medications can influence its pharmacokinetic profile.

Adverse effects

• Drowsiness
• Dizziness
• Dry mouth
• Nausea
• Constipation
• Blurred vision

Interactions

• CNS depressants may enhance sedative effects
• Antihistamines may increase the risk of adverse effects
• MAO inhibitors can lead to increased toxicity

Precautions

• Use with caution in patients with a history of seizures
• Monitor for sedation in elderly patients
• Consider potential for drug interactions

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Not recommended while breastfeeding due to potential effects on the infant.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Tablets
• Capsules
• Oral solution